Most companies revert to their SPP price and so it has proved to...

Most companies revert to their SPP price and so it has proved to be with TOX. Took months but now 7c below the CR price of 2.55. Latest update indicates 2h will exceed 1H but not enough to cover the increase in share #. Hence EPS will match 1H at best is my take.

So does that make TOX a buy at say $2.50? Def not a bargain but its enough to get me to have topped-up at 2.47 just b4 close. Anyone else buying?

PS. Only getting 20% of my allocation at CR has proved a blessing in disguise.